Both T and non-T cells with proliferating potentials are effective in inducing suppression of allograft responses by alloantigen-specific intravenous presensitization combined with suboptimal doses of 15-deoxyspergualin

Transplant Immunology

Volumn 13, Issue 1, 2004, Pages 25-32

  Tahara, Hideo ^a   Iwanami, Norimasa ^a,b   Tabata, Nobutada ^a   Matsumura, Haruo ^a   Matsuura, Takeshi ^a   Kurita, Takashi ^a   Miyazawa, Masaaki ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b RIKEN   (Japan)

Author keywords

15 deoxysupergualin; B6, C57BL 6; Con A, concanavalin A; CTL, cytotoxic T lymphocyte; Donor specific intravenous presensitization; DSG, 15 deonxysupergualin; DSP, donor specific intravenous presensitization; Skin graft; Tolerance; Veto cell

Indexed keywords

15 DEOXYSPERGUALIN; RAPAMYCIN; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG DOSE REGIMEN; GRAFT REJECTION; GRAFT SURVIVAL; INJECTION SITE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; SKIN ALLOGRAFT; SPLEEN CELL; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD; CELL PROLIFERATION; CELL TRANSPLANTATION; GRAFT ENHANCEMENT, IMMUNOLOGIC; GRAFT REJECTION; GUANIDINES; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAVENOUS; ISOANTIGENS; MICE; SKIN TRANSPLANTATION; SPLEEN; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION TOLERANCE;

EID: 2942525788     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2004.01.004     Document Type: Article

References (30)

1. Soulillou J.-P. Donor-specific transfusion-induced tolerance: mechanisms revisited. Transplant Proc. 30:1998;2438-2440
2. Rossini A.A., Mordes J.P., Markees T.G., Phillips N.E., Gordon E.J., Greiner D.L. Induction of islet transplantation tolerance using donor-specific transfusion and anti-CD154 monoclonal antibody. Transplant Proc. 31:1999;629-632
3. Okazaki H., Maki T., Wood M., Monaco A.P. Effect of a single transfusion of donor-specific and non-specific blood on skin allograft survival in mice. Transplantation. 30:1980;421-444
4. Niessen G.J.C., Marquet R.L., Bijnen A.B., Obertop H., Jeekel J. The effect of cyclosporin A and blood transfusions on cardiac allograft survival in rats. Surgery. 9:1982;339-342
5. Shelby J., Wakely E., Corry R.J. Suppressor cell induction in donor-specific transfused mouse heart recipients. Surgery. 96:1984;296-301
6. Wood M.L., Monaco A.P. Induction of unresponsiveness to skin allografts in adult mice disparate at defined regions of the H-2 complex. Transplantation. 37:1984;39-42
7. Wood K.J., Evins J., Morris P.J. Suppression of renal allograft rejection in the rat by class I antigens on purified erythrocytes. Transplantation. 39:1985;56-62
8. Martinelli G.P., Horowitz C., Chiang K., Rosels D., Schnauzer H. Pretransplant conditioning with donor-specific transfusions using heated blood and cyclosporin. Transplantation. 43:1987;140-145
9. Quigley R.L., Wood K.J., Moms P.J. Investigation of the mechanism of active enhancement of renal allograft survival by blood transfusion. Immunology. 1963:1988;373-381
10. Yang L., DuTemple B., Khan Q., Zhang L. Mechanisms of long-term donor-specific allograft survival induced by pretransplant infusion of lymphocytes. Blood. 91:1998;324-330
11. Yang C.-P., Shittu E., McManus B., Wood P.J., Bell E.B. Contrasting outcomes of donor-specific blood transfusion. Transplantation. 66:1998;639-645
12. Last W.M., van Twuyver E., Mooijaartd R.J.D., et al. Mechanisms of skin allograft enhancement across an H-2 class I mutant difference. Evidence for involvement of veto cells. Eur J Immunol. 18:1988;2105-2108
13. van Twuyver E., Kast W.M., Mooijaart R.J.D., Melief C.J.M., de Waal L.P. Induction of transplantation tolerance by intravenous inject an of allogeneic lymphocytes across an H-2 class II mismatch. Different mechanisms operate in tolerization across an H-2 class I vs. H-2 class II disparity. Eur J Immunol. 20:1990;441-444
14. Kitagawa S., Iwata H., Sato S., Shimizu J., Hamaoka T., Fujiwara H. Heterogenous graft rejection pathways in class I major hist compatibility complex-disparate combinations and their differential susceptibility to immunomodulation induced by intravenous presensitization with relevant alloantigens. J Exp Med. 174:1991;571-581
15. Sato S., Iwata H., Kitagawa S., et al. The lymphoid cell populations required for induction of tolerance of different subsets of alloantigen-reactive T cells. Transplantation. 52:1991;862-867
16. Iwata H., Kitagawa S., Sato S., et al. Suppression of allograft responses by combining donor alloantigen-specific intravenous presensitization with suboptimal doses of FK 506. Transplantation. 56:1993;173-180
17. Iwata H., Nagano T., Toyo-oka K., Hirose H., Hamaoka T., Fujiwara H. Suppression of allograft responses by combining alloantigen-specific i.v. presensitization with suboptimal doses of rapamycin. Int Immunol. 6:1994;93-99
18. Zhang Z.-X., Yang L., Young K.J., DuTemple B., Zhang L. Identification of a previously unknown antigen-specific regulatory T cell and its mechanisms of suppression. Nat Med. 6:2000;782-789
19. Iwanami N., Niwa A., Yasutomi Y., Tabata N., Miyazawa M. Role of natural killer cells in resistance against Friend retrovirus-induced leukemia. J Virol. 75:2001;3152-3163
20. Billingham R.E., Medawar P.B. Technique of free skin grafting in mammals. J Exp Biol. 28:1951;385-402
21. Abraham R.T., Wiederrecht G.J. Immunopharmacology of rapamycin. Ann Rev Immunol. 14:1996;483-510
22. Ken P.G., Nikolic-Patterson D.J., Lan H.Y., Tesch G., Tainone S., Atkins R.C. Deoxyspergualin suppresses local macrophage proliferation in rat renal allograft rejection. Transplantation. 58:1994;596-601
23. Wang B., Benoist C., Mathis D. The Immunosuppressant 1, 5-deoxyspergualin reveals commonality between preT and preB cell differentiation. J Exp Med. 183:1996;2427-2436
24. Abe M., Thomson A.W. Influence of immunosuppressive drugs on dendritic cells. Transplant Immunol. 11:2003;357-365
25. Charlton B., Auchincloss H., Fathman C.G. Mechanisms of transplantation tolerance. Ann Rev Immunol. 12:1994;707-734
26. Fink P.J., Shimonkevitz R.P., Bevan M.J. Veto cells. Ann Rev Immunol. 6:(21):1988;115-137
27. Wagner H.K. Induction of peripheral tolerance to class I major histocompatibility complex (MHC) alloantigens in adult mice: transfused class I MHC-incompatible splenocytes veto clonal responses of antigen-reactive Lyt-2+ T cells. J Exp Med. 172:1990;719-728
28. Tscherning T., Claesson M.H. Veto suppression: the peripheral way of T cell tolerization. Exp Clin Immunogenet. 10:1993;179-188
29. + CTLs as potent veto cells: coexpression of CD8 and FasL is a prerequisite. Immunity. 13:2000;507-515
30. Madsen J.C., Superina R.A., Wood K.J., Morris P.J. Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes. Nature. 332:1988;161-164